Estadisticas : Safety, reactogenicity, and immunogenicity of MTBVAC in infants: a phase 2a randomised, double-blind, dose-defining trial in a TB endemic setting

Tameris, Michele
Visitas:441

215 ( Estados Unidos de América )

74 ( Singapur )

34 ( Hong kong )

21 ( Reino Unido )

14 ( Finlandia )

12 ( Brasil )

12 ( China )

11 ( Alemania )

7 ( Francia )

7 ( Letonia )

4 ( Bélgica )

4 ( India )

4 ( Vietnam )

2 ( Rusia )

2 ( Colombia )

2 ( Canadá )

2 ( Uruguay )

2 ( España )

1 ( Japón )

1 ( Honduras )

1 ( Venezuela )

1 ( Líbano )

1 ( Emiratos Árabes Unidos )

1 ( Italia )

1 ( Ecuador )

1 ( Australia )

1 ( Irlanda )

1 ( Marruecos )

1 ( Arabia Saudita )

1 ( Austria )

Descargas: 152